Search research articles
Contact Us
Filters
Showing results (271-280 of 520) with videos related to
Page
of 52
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
February 19, 2011
PET and PET/CT for unknown primary tumors
Thomas C Kwee, Sandip Basu, Abass Alavi
World Journal of Nuclear Medicine
|
May 24, 2023
Sellar-Parasellar and Petrous Bone Metastasis from Differentiated Thyroid Carcinoma: Imaging Characteristics and Follow-Up Profile Post Radioiodine Therapy
Sunita Nitin Sonavane, Trupti Upadhye, Sandip Basu
European Journal of Nuclear Medicine and Molecular Imaging
|
October 20, 2019
Availability of both [<sup>177</sup>Lu]Lu-DOTA-TATE and [<sup>90</sup>Y]Y-DOTATATE as PRRT agents for neuroendocrine tumors: can we evolve a rational sequential duo-PRRT protocol for large volume resistant tumors?
Sandip Basu, Rahul V Parghane, Sharmila Banerjee
Hellenic Journal of Nuclear Medicine
|
December 6, 2015
How a tertiary medical nuclear medicine department at the Himalayan area in India can be established and function in an exemplary manner. Basic rules revisited
Vandana Kumar Dhingra, Sunil Saini, Sandip Basu
PET Clinics
|
May 10, 2016
PET and PET/CT Assessment of Gynecologic Malignancies: Beyond FDG
Sandip Basu, Thomas C Kwee, Abass Alavi
European Journal of Nuclear Medicine and Molecular Imaging
|
May 28, 2014
Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT
Sandip Basu, Bhawna Sirohi, Shailesh V Shrikhande
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India
|
November 24, 2025
Tissue and Organ-specific Tumor Heterogeneity on dual tracer PET-CT ([<sup>68</sup>Ga] Ga-PSMA-11 and [<sup>18</sup>F] FDG) and Dural-based Brain metastasis in Metastatic Prostate Cancer
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
Clinical Nuclear Medicine
|
January 9, 2025
Central Nervous System Tumor-Embryonal Tumors Type With Neuroendocrine Differentiation
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
World Journal of Nuclear Medicine
|
December 16, 2024
Aggressive Metastatic Insulinoma in a Patient of Diabetes Mellitus with Documentation on Dual-Tracer PET-CT ([68Ga]Ga-DOTATATE and [18F]FDG): Clinical Benefits with Combined Chemo-PRRT Approach
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
Current Oncology (Toronto, Ont.)
|
October 27, 2023
Application of Machine Learning in Predicting Hepatic Metastasis or Primary Site in Gastroenteropancreatic Neuroendocrine Tumors
Mahesh Kumar Padwal, Sandip Basu, Bhakti Basu
Page
of 52
Search research articles
Search
Showing results (271-280 of 520) with videos related to
Sort By:
Page
of 52
Methods in Molecular Biology (Clifton, N.J.)
|
February 19, 2011
PET and PET/CT for unknown primary tumors
Thomas C Kwee, Sandip Basu, Abass Alavi
World Journal of Nuclear Medicine
|
May 24, 2023
Sellar-Parasellar and Petrous Bone Metastasis from Differentiated Thyroid Carcinoma: Imaging Characteristics and Follow-Up Profile Post Radioiodine Therapy
Sunita Nitin Sonavane, Trupti Upadhye, Sandip Basu
European Journal of Nuclear Medicine and Molecular Imaging
|
October 20, 2019
Availability of both [<sup>177</sup>Lu]Lu-DOTA-TATE and [<sup>90</sup>Y]Y-DOTATATE as PRRT agents for neuroendocrine tumors: can we evolve a rational sequential duo-PRRT protocol for large volume resistant tumors?
Sandip Basu, Rahul V Parghane, Sharmila Banerjee
Hellenic Journal of Nuclear Medicine
|
December 6, 2015
How a tertiary medical nuclear medicine department at the Himalayan area in India can be established and function in an exemplary manner. Basic rules revisited
Vandana Kumar Dhingra, Sunil Saini, Sandip Basu
PET Clinics
|
May 10, 2016
PET and PET/CT Assessment of Gynecologic Malignancies: Beyond FDG
Sandip Basu, Thomas C Kwee, Abass Alavi
European Journal of Nuclear Medicine and Molecular Imaging
|
May 28, 2014
Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT
Sandip Basu, Bhawna Sirohi, Shailesh V Shrikhande
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India
|
November 24, 2025
Tissue and Organ-specific Tumor Heterogeneity on dual tracer PET-CT ([<sup>68</sup>Ga] Ga-PSMA-11 and [<sup>18</sup>F] FDG) and Dural-based Brain metastasis in Metastatic Prostate Cancer
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
Clinical Nuclear Medicine
|
January 9, 2025
Central Nervous System Tumor-Embryonal Tumors Type With Neuroendocrine Differentiation
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
World Journal of Nuclear Medicine
|
December 16, 2024
Aggressive Metastatic Insulinoma in a Patient of Diabetes Mellitus with Documentation on Dual-Tracer PET-CT ([68Ga]Ga-DOTATATE and [18F]FDG): Clinical Benefits with Combined Chemo-PRRT Approach
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
Current Oncology (Toronto, Ont.)
|
October 27, 2023
Application of Machine Learning in Predicting Hepatic Metastasis or Primary Site in Gastroenteropancreatic Neuroendocrine Tumors
Mahesh Kumar Padwal, Sandip Basu, Bhakti Basu
Page
of 52